PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 11 analysts with an average price target of $28.86. This is a potential upside of $9.03 (45.54%) from yesterday's end of day stock price of $19.83.

Pacira Pharmaceuticals's activity chart (see below) currently has 239 price targets and 241 ratings on display. The stock rating distribution of PCRX is 9.26% HOLD and 90.74% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.78% with an average time for these price targets to be met of 324.67 days.

Highest price target for PCRX is $57, Lowest price target is $10, average price target is $28.86.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 04-Dec-2024. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 5 are a HOLD (9.26%), 49 are a BUY (90.74%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$39

$19.14 (96.37%)

$39

14 days ago
(04-Dec-2024)

13/27 (48.15%)

$21.25 (119.72%)

233

Hold

$17

$-2.86 (-14.40%)

$25

1 months 6 days ago
(12-Nov-2024)

3/11 (27.27%)

$0.06 (0.35%)

291

Buy

$22

$2.14 (10.78%)

$22

1 months 10 days ago
(08-Nov-2024)

2/17 (11.76%)

$4.76 (27.61%)

878

Hold

$16

$-3.86 (-19.44%)

$15

1 months 11 days ago
(07-Nov-2024)

1/9 (11.11%)

$-1.9 (-10.61%)

11

Buy

$37

4 months 6 days ago
(12-Aug-2024)

22/26 (84.62%)

$16.35 (79.18%)

55

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 324.67 days on average for the stock forecasts to be realized with a an average price target met ratio 68.78

Which analyst has the current highest performing score on PCRX (Pacira Pharmaceuticals) with a proven track record?

LIANA MOUSSATOS

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with highest potential upside - $74.14

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

Irina Koffler with lowest potential downside - -$11.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?